Genetic Signatures Ltd ABN 30 095 913 205 7 Eliza Street, Newtown NSW 2042 Telephone + 612 9870 7580 Email: investors@geneticsignatures.com ASX Announcement 8 October 2026 Quarterly Activities Report and Appendix 4C HIGHLIGHTS • Genetic Signatures closed Q1 FY2027 with $20.9 million in cash...
Quarterly Activities/Appendix 4C Cash Flow Report
Earlier from Genetic Signatures
- GSS Investor Presentation - Proposed Merger with MAP
- Receipt of Section 249D Notice from BCAL Diagnostics
- BDX Holdings of GSS Shares and receipt of Section 249D
- Genetic Signatures and Microba in Merger Discussions

